VEDS Upcoming Clinical Trial Q&A with Aytu BioPharma and Hal Dietz, MD (AR101- Enzastuarin)

July 11, 2021 1:30 pm 2:30 pm ET Recorded

Nate Massari and Topher Brooke, with Aytu BioPharma, along with Hal Dietz, MD, will provide a brief background on the research leading up to the upcoming clinical trial for AR101 (Enzastaurin) for VEDS, and answer questions about steps in planning the trial and possible timeline.